DOCSLIB.ORG

Boswellic Acids in Chronic Inflammatory Diseases Review

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Boswellic Acids in Chronic Inflammatory Diseases Review H. P. T. Ammon Boswellic Acids in Chronic Inflammatory Diseases Review Abstract CHE: Cholinesterase Con A: Concanavalin A Oleogum resins from Boswellia species are usedin traditional COX1: Cyclooxygenase 1 medicine in India and African countries for the treatment of a COX2: Cyclooxygenase 2 variety of diseases. Animal experiments showed anti-inflamma- cPLA: Phospholipase A tory activity of the extract. The mechanism of this action is due to CRP: C-reactive protein some boswellic acids. It is different from that of NSAID and is EC50: Effective concentration 50 relatedto components of the immune system. The most evident ESR: Erythrocyte sedimentation rate action is the inhibition of 5-lipoxygenase. However, other factors FEV1: Forcedexpiratory volume in 1 sec (liters) such as cytokines (interleukins andTNF- a) andthe complement FLAP: 5-Lipoxygenase activating protein system are also candidates. Moreover, leukocyte elastase and fMLP: n-Formyl-methionyl-leucyl-phenylalanin oxygen radicals are targets. Clinical studies, so far with pilot FVC: Forcedvital capacity (liters) character, suggest efficacy in some autoimmune diseases includ- HAB: Homöopathisches Arzneibuch ing rheumatoidarthritis, Crohn's disease,ulcerative colitis and (German homeopathic pharmacopoeia) bronchial asthma. Side effects are not severe when compared to 5-HETE: 5-Hydroxyeicosatetraenoic acid modern drugs used for the treatment of these diseases. 12-HETE: 12-Hydroxyeicosatetraenoic acid 12-HHT: 12-Hydroxyheptadecatrienoic acid Key words HLE: Human leucocyte elastase Boswellic acids ´ anti-inflammatory actions ´ immune system ´ IC50: Inhibitory concentration 50 leukotrienes ´ chronic bowel diseases ´ arthritis ´ bronchial asth- 5-LO: 5-Lipoxygenase ma IKK: IkBa kinase IL-1: Interleukin-1 Abbreviations IL-2: Interleukin-2 AKBA: Acetyl-11-keto-b-boswellic acid KBA: 11-Keto-b-boswellic acid BA: Boswellic acid LPS: Lipopolysaccharide BE: Extract from oleogum resin of Boswellia serrata LTB4: Leukotriene B4 BS: Boswellia serrata LTC4: Leukotriene C4 BSA: Bovine serum albumin LTD4: Leukotriene D4 2+ This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. [Ca ]: Cytosolic calcium concentration LTE4: Leukotriene E4 Affiliation Dept. of Pharmacology, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany Dedication In memory of Prof. E. Reinhard Correspondence Prof. H. P. T. Ammon ´ Pharmakologie ´ Universität Tübingen ´ Auf der Morgenstelle 8 ´ 72076 Tuebingen ´ Germany ´ Phone: +49-7071-297-4675 ´ Fax: +49-7071-392-476 ´ E-mail: [email protected] Received April 24, 2006 ´ Accepted June 15, 2006 Bibliography Planta Med Georg Thieme Verlag KG Stuttgart ´ New York DOI 10.1055/s-2006-947227 ´ Publishedonline 2006 ISSN 0032-0943 MAPK: Mitogen activatedprotein kinase PHA: Phytohaemagglutinin MCH: Mean corpuscular haemoglobin PI3-K: Phosphatidylinositol 3-kinase MCHC: Mean corpuscular haemoglobin concentration PMNs: Polymorphonuclear neutrophils MCV: Mean corpuscular volume RAS: 21 kDA-GTP-binding protein MEK: Mitogen activatedprotein kinase kinase TA: Tirucallic acid NSAID: Non-steroidal anti-inflammatory drug TH1: T-Helper cells 1 P38: p38 kinase TH2: T-Helper cells 2 P42: p42 kinase TNFa: Tumor necrosis factor a PEFR: Peak expiratory flowrate PGF 1a: Prostaglandin F 1a nd th Review Introduction 2 century AD andin Astangahrdaya Samhita, 7 century AD). Medical preparations containing the bark or the oleogum resin In the last decade preparations from the oleogum resin of were used to treat a variety of diseases. These included diseases Boswellia serrata (BS) andother Boswellia species, also called of the respiratory tract like cough, other respiratory problems, as frankincense or olibanum, have become more andmore popular well as diarrhoea, constipation, flatulence, central nervous dis- in some European countries for the treatment of a variety of eases andothers (Table 1). chronic inflammatory diseases including rheumatoid arthritis, chronic bowel diseases, bronchial asthma, peritumoural brain Olibanum was still a remedy in the beginning of the 20th century oedema and others. This review summarises the present evi- in Europe. Thus, olibanum is mentionedin the supplement to the dence of pharmacological actions and clinical outcome of bos- 6th edition of the German Pharmacopoeia, which appeared in wellic preparations with special reference to the actions of bos- 1926. Thereafter, olibanum disappeared from medical treat- wellic acids. ments due to the lack of scientific evidence be it pharmacological or clinical. Scientists of the Regional Research Laboratory in Jam- mu (India) were the first to describe anti-inflammatory proper- Historical Background ties of an extract of the oleogum resin of BS in animal models in the years up to 1986. After the detection of the inhibitory effects Incense was known to all the ancient civilisations andusedin ri- of the extract on leukotriene synthesis in 1991, the subject re- tuals andprayers to the gods.Frank (ªpureº) incense andmyrrh ceivedlarge interest in the scientific world. were the finest andmost scarce, producedonlyin a small area of the Arabian peninsula, Somalia andEthiopia. Because of their rarity andgreat cost, the gifts of the Magi were a sign of wealth and sacrifice. Beyond that, there is medical evidence that gold, Table 1 Therapeutic uses of Salai guggal in the traditional Indian Ayurvedic medicine (from [2]) frankincense andmyrrh were important for woundhealing, usedby many cultures andsocieties for thousandsof years. The Organs and functional systems Effects Babylonians, Hindus, Buddhists, Chinese, Shintoists, Greeks and Romans incorporatedthe use of incense in their ritualistic cere- Nervous system Analgesic monies. Mental tonic Stimulation Eye tonic The oldest written document, which mentions frankincense as a Cardiovascular system Cardiotonic drug is the papyrus Ebers. In 1873, the Professor of Egyptology, Gastrointestinal tract Regulating colour of stool Moritz Fritz Ebers receiveda more than 20 m long papyrus from Carminative, stomachic an Arab businessman. It hadbeen foundeleven years before be- Improving digestion, antidiarrhoeic Improving taste tween the legs of a mummy in Luxor. It containedpractical infor- Anthelmintic This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. mation for medical doctors regarding diagnosis and treatment of Urogenital system Diuretic internal diseases with about 900 prescription formulae. It was Aphrodisiac Improving menstruation probably written about 1500 BC at the time of Pharaoh Ameno- Fever Antipyretic phis I [1]. Skin Increases perspiration Wound cleaning Remedies containing preparations from frankincense (here Whole organism Anti-inflammatory Boswellia carterii Birdw.) were used by Hippocrates, Celcus, Gale- Antiseptic nus andDioskurides[1]. Main external uses of Boswellia carterii Reducing fat Haemostypic Birdw. preparations were treatment of tumours, carcinomas and Connecting tissue oedemas. Moreover, inflammatory diseases including diarrhoea Decreasing Kapha diseases and diseases of the respiratory tract were treated. (in Ayurvedic nomenclature) The use of the oleogum resin of Boswellia serrata (BS) salai gug- gal is described in Ayurvedic text books (Charaka Samhita, 1st - Ammon P. Boswellic Acids in¼ Planta Med Botanical Aspects thors reported marked differences in different species. A striking difference was observed in the content of the main active bos- Incense is the oleogum resin produced in the bark of different wellic acids AKBA and KBA. It is evident that the Indian sample Boswellia species belonging to the family of Burseraceae. Some containedquite similar amounts of AKBA andKBA whereas the of them are listedin Table 2. African samples containedless KBA than AKBA. Interestingly, as discussed later, in pharmacokinetic studies with extracts from The author is aware that the chapters dealing with the historical Boswellia serrata oleogum resin only little AKBA was foundin and botanical aspects are rather incomplete and, for details, the the plasma if comparedto KBA. A new pentacyclic triterpene study of special historical, botanical and phytochemical litera- from BS, i.e., 3a-acetyl-20(29)-lupene-24-oic acidwas recently ture [1] is suggested. identified by Beisner et al. [4]. Employing a commercial extract from BS (H 15 AyurmedicaTM), ~2.6 mg/100 mg KBA and ~2.8 mg/100 mg AKBA were detected on average in 11 different Composition of Oleogum Resins lots [5]. Ganzera et al. [6] studied 4 different commercial pro- ducts containing the oleogum resin of BS together with up to 10 Review More than 200 different compounds were identified in the oleo- other plant extracts. Considering the manufacturer's dosing re- gum resin of different Boswellia species. Main components are commendations, the daily intake of total boswellic acids varies volatile oil, pure resin andmucus. The content of these differs up to 6-fold(18.49 to 109.62 mg per day).Hamm et al. [7] tested from species to species, between different harvestings and differ- volatile andsemi-volatile terpenes from 6 differentolibanum ent locations. An approximate composition of some oleogum re- samples, i.e., B. carterii, B. sacra, B. serrata, B. papyfera and B. sins is listedin Table 3. The resins of Boswellia species contain frereana. The chemical composition was different in all species pentacyclic andtetracyclic triterpenes. Among the pentacyclic andallowedidentification of the taxonomic
Load more

Recommended publications
  • Cop18 Doc. 66
    Original language: English CoP18 Doc. 66 CONVENTION ON INTERNATIONAL TRADE IN ENDANGERED SPECIES OF WILD FAUNA AND FLORA ____________________ Eighteenth meeting of the Conference of the Parties Colombo (Sri Lanka), 23 May – 3 June 2019 Species specific matters TRADE IN BOSWELLIA SPP. (BURSERACEAE) 1. This document has been submitted by Sri Lanka and the United States of America.* Overview 2. The genus Boswellia is the source of the aromatic resin known as frankincense, a semi-solid, yellow-brown substance derived from the gummy sap of the tree. Also known as olibanum, this resin and resin-derived essential oils and alcohol extracts are widely traded internationally and are incorporated into a variety of healthcare, home care, aromatherapy, cosmetics and toiletries, and dietary supplement products. Bark, extracts of bark, wood products, and live plants of these species may also be traded internationally. Boswellia species provide economic and ecological benefits across their range. However, there is growing concern that increasing demand and unregulated international trade of this high value commodity might threaten the survival of these species. This document provides background information to serve as a background and seek input from Parties and insights from the Plants Committee for further information gathering, review, and discussion to better understand the impact of international trade on these species. The species and their status 3. Boswellia species are the sole source of frankincense, also known as olibanum (Coppen 1995; Hassan Alaamri 2012). The genus includes includes about 18 small to medium tree species that are native to the arid tropical regions of Africa, the Middle East, and South Asia.
    [Show full text]
  • Research Opinions in Animal & Veterinary Sciences
    www.roavs.com EISSN: 2223-0343 ReseaRch OpiniOns in animal & VeteRinaRy sciences Research article DOI: 10.20490/ROAVS/16-023 Effect of Olibanum (Boswellia thurifera) as a feed additive on performance, some blood biochemical and intestinal morphology in broiler chicks Sayeed Nouraldin Tabatabaei Department of Animal Sciences, Khorasgan (Isfahan) Branch, Islamic Azad University, Isfahan, Iran Article history Abstract Received: 7 Mar, 2016 To determine the effect of Olibanum on performance, some blood biochemical and Revised: 20 May, 2016 intestinal morphology of broiler chicks, a total 360 one day Ross 308 broiler chicks Accepted: 27 May, 2016 were divided into 6 dietary treatments. The chicks were fed a basal diet as control; basal diet with 0.01% (T1), 0.015% (T2), 0.02% (T3), 0.03% (T4) and 0.05% (T5) of Olibanum. No significant difference was found in feed intake, weight gain and feed conversion ratio between the control and treated groups. Serum triglyceride level decreased significantly (P<0.05) in T1, T2 and T3 compared to the control. Villus length of ilium increased significantly (P<0.05) in T2. In conclusion, it seems that inclusion of Olibanum as feed additive may have significantly enhanced effects on performance and some blood biochemical in broiler chicks. Keywords: Performance; broilers; blood parameters; Olibanum; intestinal morphology To cite this article: Tabatabaie SN, 2016. Effect of Olibanum (Boswellia thurifera) as a feed additive on performance, some blood biochemical and intestinal morphology in broiler chicks. Res. Opin. Anim. Vet. Sci., 6(4): 130-134. Introduction possess anti diarrheal effect, which may be related to anti cholinergic mechanisms (Etuk et al., 2006).
    [Show full text]
  • Original Articles Enhancement of Leukotriene B4 Release in Stimulated Asthmatic Neutrophils by Platelet Activating Factor
    1024 Thorax 1997;52:1024±1029 Thorax: first published as 10.1136/thx.52.12.1024 on 1 December 1997. Downloaded from Original articles Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor Kunihiko Shindo, Kohei Koide, Motonori Fukumura Abstract of phospholipase A2 and acetyltransferase on Background ± The role of platelet ac- membrane alkylacyl phospholipids. PAF was tivating factor (PAF) in asthma remains originally described as a substance released controversial. The priming eVect of PAF from basophils sensitised with IgE.1 on leukotriene B4 (LTB4) release, 5-lip- The stimulation of neutrophils by PAF res- oxygenase activity, and intracellular cal- ults in the release of lysosomal enzymes and cium levels in asthmatic neutrophils was superoxide anions and the generation of leuko- 23 examined. triene (LT) B4. The biological eVects of Methods ±LTB4 and other lipoxygenase PAF, including airway microvascular leakage, metabolites in neutrophils obtained from bronchoconstriction, sustained increase in 17 asthmatic patients and 15 control sub- bronchial smooth muscle responsiveness, and jects were measured by reverse phase-high pulmonary vasoconstriction, mimic many clin- performance liquid chromatography (RP- ical features of asthma. Thus, PAF has been HPLC). Intracellular calcium levels were considered an important mediator in asthma monitored using the ¯uorescent probe as well as in other lung disorders.4 However, fura-2. clinical studies56 with PAF receptor antagonist Results ± The mean (SD)
    [Show full text]
  • Montelukast, a Leukotriene Receptor Antagonist, Reduces the Concentration of Leukotrienes in the Respiratory Tract of Children with Persistent Asthma
    Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma Benjamin Volovitz, MD,a,b Elvan Tabachnik, MD,c Moshe Nussinovitch, MD,b Biana Shtaif, MSc,b Hanna Blau, MD,a Irit Gil-Ad, PhD,b Abraham Weizman, MD,b and Itzhak Varsano, MDa,b Petah Tikva, Tel Aviv, and Rehovot, Israel Background: Leukotrienes are bronchoactive mediators secreted by inflammatory cells in the respiratory mucosa on Abbreviations used exposure to asthma triggers. BAL: Bronchoalveolar lavage Objective: We investigated the effect of montelukast, a CysLT1: Cysteinyl leukotriene 1 (receptor) leukotriene receptor antagonist, on the release of leukotrienes ECP: Eosinophilic cationic protein in the respiratory mucosa of children with persistent asthma. LTC4: Leukotriene C4 Method: Twenty-three children aged 6 to 11 years with moder- LTD4: Leukotriene D4 ately severe asthma were treated in a cross-over design start- LTE4: Leukotriene E4 ing, after a 2-week run in period, with either montelukast (n = 12) or cromolyn (n = 11) for 4 weeks with a 2-week washout period between treatments. Twelve of them were then treated Cysteinyl leukotrienes are potent proinflammatory with either montelukast or beclomethasone for 6 months. The mediators produced from a variety of inflammatory use of β -agonists was recorded on a diary card. The concen- 2 cells, including mast cells, eosinophils, basophils and tration of leukotriene C4 (LTC4) was measured by HPLC in nasal washes obtained before and at the end of each treatment macrophages. Leukotriene C4 (LTC4) is metabolized period. Eosinophilic cationic protein (ECP) was measured in enzymatically to leukotriene D4 (LTD4) and subsequent- the nasal washes by RIA.
    [Show full text]
  • Anti-Inflammatory Herbal Gel of Boswellia Serrata & Vitex Negundo
    Available Online through www.ijpbs.com (or) www.ijpbsonline.com IJPBS |Volume 3| Issue 2 |APR-JUN |2013|41-49 Review Article Pharmaceutical Sciences REVIEW ON: ANTI-INFLAMMATORY HERBAL GEL OF BOSWELLIA SERRATA & VITEX NEGUNDO Garje K.L * & K.S. Salunkhe Department of Pharmaceutics Amrutvahini College of Pharmacy, Amrutnagar, Sangamner (S.K.) 422608, (Maharashtra), India *Corresponding Author Email: [email protected] ABSTRACT Herbal medicine has become a global importance both medicinal and economical. Although usage of these herbal medicines has increased, their quality, safety and efficiency are serious concerns in industrialized and developing countries. Plant play a vital role in curing various ailments of the man and herbal remedies are getting increasing patient compliance as they are devoid of typical side effects of allopathic medicines. The allopathic system of medicine includes two conventional line of the treatment for rheumatoid arthritis, which come along with certain side effects. Hence, turning to safe, effective and time tested ayuvedic herbal drug formulation would be a preferable option. So there is need to investigate such drugs and their effective formulation for the better patient acceptance. Considering these facts present review aims to develop novel herbal gel containing the herbs, viz Vitex Negundo and Boswellia serrata. The present study deals that herbal gels formulation of the Vitex Negundo and Boswellia serrata extract using different polymer carbopol gel as the gelling agents and different evaluation parameters provides the effective anti-inflammatory activity to treatment of the inflammation, pain, arthritis etc patients problems. This review focus on the current status of the therapeutic potential and phytochemical profile on the herbal anti –inflammatory agents as Vitex Negundo and Boswellia serrata.
    [Show full text]
  • Disruption of the Alox5ap Gene Ameliorates Focal Ischemic Stroke: Possible Consequence of Impaired Leukotriene Biosynthesis
    Ström et al. BMC Neuroscience 2012, 13:146 http://www.biomedcentral.com/1471-2202/13/146 RESEARCH ARTICLE Open Access Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis Jakob O Ström1, Tobias Strid2 and Sven Hammarström2* Abstract Background: Leukotrienes are potent inflammatory mediators, which in a number of studies have been found to be associated with ischemic stroke pathology: gene variants affecting leukotriene synthesis, including the FLAP (ALOX5AP) gene, have in human studies shown correlation to stroke incidence, and animal studies have demonstrated protective properties of various leukotriene-disrupting drugs. However, no study has hitherto described a significant effect of a genetic manipulation of the leukotriene system on ischemic stroke. Therefore, we decided to compare the damage from focal cerebral ischemia between wild type and FLAP knockout mice. Damage was evaluated by infarct staining and a functional test after middle cerebral artery occlusion in 20 wild type and 20 knockout male mice. Results: Mortality-adjusted median infarct size was 18.4 (3.2-76.7) mm3 in the knockout group, compared to 72.0 (16.7-174.0) mm3 in the wild type group (p < 0.0005). There was also a tendency of improved functional score in the knockout group (p = 0.068). Analysis of bone marrow cells confirmed that knockout animals had lost their ability to form leukotrienes. Conclusions: Since the local inflammatory reaction after ischemic stroke is known to contribute to the brain tissue damage, the group difference seen in the current study could be a consequence of a milder inflammatory reaction in the knockout group.
    [Show full text]
  • Antibacterial Effect of Thymus Sp. and Boswellia Sp. Extracts on Streptococcus Pneumoniae and Klebsiella Pneumoniae Isolates
    Vol. 17(5), pp. 133-138, 31 January, 2018 DOI: 10.5897/AJB2017.16051 Article Number: 0CCB56455822 ISSN 1684-5315 African Journal of Biotechnology Copyright © 2018 Author(s) retain the copyright of this article http://www.academicjournals.org/AJB Full Length Research Paper Antibacterial effect of Thymus sp. and Boswellia sp. extracts on Streptococcus pneumoniae and Klebsiella pneumoniae isolates Sahar K. Al-Dosary Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, P. O. Box 2233 – Dammam 31311, Kingdom of Saudi Arabia (KSA). Received 30 April, 2017; Accepted 18 October, 2017 The antimicrobial activity of essential oils of Boswellia and thyme (Boswellia sp., and Thyme sp.) was evaluated against 20 clinical isolates of Streptococcus pneumoniae and 5 isolates of Klebsiella pneumoniae. Essential oils were prepared using methanol and water (1:1) with HPLC technique. Antimicrobial activity and minimum inhibitory concentration (MIC) were measured using disk diffusion method against 20 isolates of S. pneumoniae and 5 isolates of K. pneumoniae isolated from different patients. Flavonoids and phenolic compounds are the main constituents of Boswellia and thyme which may have the antimicrobial activity. Boswellia extract was more efficient than thyme extracts; 60% of S. pneumoniae isolates and one K. pneumoniae isolate were sensitive to Boswellia extract, 30% of S. pneumoniae isolates were sensitive to thyme extract, and no effect on K. pneumoniae clinical isolates was observed. Inhibition zones ranged from 1-12 mm with thyme extract, while Boswellia extracts showed 2 to 30 mm diameters of inhibition zone. This study is significant due to the widespread problem of microbial drug resistance and the need for natural antibiotic to fight diseases.
    [Show full text]
  • LEUKOTRIENE A4 HYDROLASE Martin J. Mueller
    Department of Medical Biochemistry and Biophysics, Division of Chemistry II, Karolinska Institutet, 171 77 Stockholm, SWEDEN LEUKOTRIENE A4 HYDROLASE Identification of amino acid residues involved in catalyses and substrate-mediated inactivation Martin J. Mueller Stockholm 2001 Published and printed by Karolinska University Press Box 200, SE-171 77 Stockholm, Sweden © Martin J. Mueller, 2001 ISBN 91-628-4934-4 Abstract Leukotriene (LT) A4 hydrolase catalyzes the committed step in the biosynthesis of LTB4, a classical chemoattractant and immune-modulating lipid mediator involved in inflammation, host-defense against infections, and systemic, PAF-mediated, lethal shock. LTA4 hydrolase is a bifunctional zinc metalloenzyme with a chloride-stimulated arginyl aminopeptidase activity. When exposed to its lipid substrate LTA4, the enzyme is inactivated and covalently modified in a process termed suicide inactivation, which puts a restrain on the enzyme's ability to form the biologically active LTB4. In the present thesis, chemical modification with a series of amino acid-specific reagents, in the presence and absence of competitive inhibitors, was used to identify catalytically important residues at the active site. Thus, using differential labeling techniques, modification with the tyrosyl reagents N-acetylimidazole and tetranitromethane revealed the presence of two catalytically important Tyr residues. Likewise, modification with 2,3-butanedione and phenylglyoxal indicated that three Arg residues were located at, or near, the active center of the enzyme. Using differential Lys-specific peptide mapping of untreated and suicide inactivated LTA4 hy- drolase, a 21 residue peptide termed K21, was identified that is involved in binding of LTA4 to the native protein. Isolation and amino acid sequencing of a modified form of K21, revealed that Tyr- 378 is the site of attachment between LTA4 and the protein.
    [Show full text]
  • How Does Genome Size Affect the Evolution of Pollen Tube Growth Rate, a Haploid Performance Trait?
    Manuscript bioRxiv preprint doi: https://doi.org/10.1101/462663; this version postedClick April here18, 2019. to The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv aaccess/download;Manuscript;PTGR.genome.evolution.15April20 license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Effects of genome size on pollen performance 2 3 4 5 How does genome size affect the evolution of pollen tube growth rate, a haploid 6 performance trait? 7 8 9 10 11 John B. Reese1,2 and Joseph H. Williams2 12 Department of Ecology and Evolutionary Biology, University of Tennessee, Knoxville, TN 13 37996, U.S.A. 14 15 16 17 1Author for correspondence: 18 John B. Reese 19 Tel: 865 974 9371 20 Email: [email protected] 21 1 bioRxiv preprint doi: https://doi.org/10.1101/462663; this version posted April 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 22 ABSTRACT 23 Premise of the Study – Male gametophytes of most seed plants deliver sperm to eggs via a 24 pollen tube. Pollen tube growth rates (PTGRs) of angiosperms are exceptionally rapid, a pattern 25 attributed to more effective haploid selection under stronger pollen competition. Paradoxically, 26 whole genome duplication (WGD) has been common in angiosperms but rare in gymnosperms.
    [Show full text]
  • Crateva Adansonii
    PHYTOCHEMICAL ANALYSIS AND THE ANTI- INFLAMMATORY ACTIVITIES OF METHANOL EXTRACT OF CRATEVA ADANSONII BY UWAH LYNDA OGECHI BC/2009/262 A PROJECT SUBMITTED TO THE DEPARTMENT OF BIOCHEMISTRY IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR THE AWARD OF BACHELOR OF SCIENCE (B.SC) DEGREE IN BIOCHEMISTRY. FACULTY OF NATURAL SCIENCE CARITAS UNIVERSITY, AMORJI –NIKE EMENE, ENUGU STATE. SUPERVISOR: MR M. O. EZENWALI AUGUST, 2013 1 CERTIFICATION PAGE This is to certify that this project work was fully carried out by Uwah Lynda O. of the Department of Biochemistry, Faculty of Natural Science Caritas University –Nike Enugu State. Mr Moses Ezenwali DATE (Head of Department) …………………….. Mr Moses Ezenwali DATE Project supervisor ………………………. ……………………… External Supervisor DATE …………………… 2 DEDICATION This project work is dedicated to my creator in heaven and to my lovely parents and siblings. Who thought me to be hardworking and to my supervisor M.O Ezenwali and my humbly lecture Dr V. Ikpe. 3 ACKNOWLEDGEMENT I want to thank and acknowledge God’s almighty for his blessings in my life. I am grateful for his endless love, protection, guidance, grace upon me and my family. My sincere appreciation goes to my parents Mr. and Mrs Stephen Uwah for their love, care, prayers, advice and financial support. I also appreciate my siblings for their love. Ambrose Okeke,, friends and well-wisher. I also acknowledge the untiring effort to my supervisor Mr. Moses O. Ezenwali (H.O.D), my lecturers Dr V. Ikpe Mr P. Ugwudike, Mr Yusuf Omeh, Dr Charles Ishiwu, Mr Steve Eze Peter, who brought out their time to assist me and make suggestions to make this work a success.
    [Show full text]
  • Food and Drug Administration Center for Drug
    1 1 FOOD AND DRUG ADMINISTRATION 2 CENTER FOR DRUG EVALUATION AND RESEARCH 3 4 5 6 PHARMACY COMPOUNDING ADVISORY COMMITTEE 7 (PCAC) 8 9 10 Tuesday, March 8, 2016 11 12 Morning Session 13 8:30 a.m. to 12:20 p.m. 14 15 16 17 FDA White Oak Campus 18 10903 New Hampshire Avenue 19 Building 31 Conference Center 20 The Great Room (Rm. 1503) 21 Silver Spring, Maryland 22 2 1 Meeting Roster 2 DESIGNATED FEDERAL OFFICER (Non-Voting) 3 Cindy Hong, PharmD 4 Division of Advisory Committee and Consultant 5 Management 6 Office of Executive Programs, CDER, FDA 7 8 PHARMACY COMPOUNDING ADVISORY COMMITTEE MEMBERS 9 (Voting) 10 Michael A. Carome, MD, FASHP 11 (Consumer Representative) 12 Director of Health Research Group 13 Public Citizen 14 Washington, District of Columbia 15 16 Gigi S. Davidson, BSPh, DICVP 17 U.S. Pharmacopeial Convention 18 (USP) Representative 19 Director of Clinical Pharmacy Services 20 North Carolina State University 21 College of Veterinary Medicine 22 Raleigh, North Carolina 3 1 John J. DiGiovanna, MD 2 Staff Clinician, DNA Repair Section 3 Dermatology Branch, Center for Cancer Research 4 National Cancer Institute 5 National Institutes of Health 6 Bethesda, Maryland 7 8 Padma Gulur, MD 9 (Acting Chairperson) 10 Professor, Department of Anesthesiology and 11 Perioperative Care 12 University of California, Irvine 13 Orange, California 14 15 Stephen W. Hoag, PhD 16 Professor 17 Department of Pharmaceutical Science 18 University of Maryland, Baltimore 19 Baltimore, Maryland 20 21 22 4 1 William A. Humphrey, BSPharm, MBA, MS 2 Director of Pharmacy Operations 3 St.
    [Show full text]
  • Disruption of the Alox5ap Gene Ameliorates Focal Ischemic Stroke: Possible Consequence of Impaired Leukotriene Biosynthesis
    Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis Jakob Ström, Tobias Strid and Sven Hammarström Linköping University Post Print N.B.: When citing this work, cite the original article. Original Publication: Jakob Ström, Tobias Strid and Sven Hammarström, Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis, 2012, BMC neuroscience (Online), (13). http://dx.doi.org/10.1186/1471-2202-13-146 Licencee: BioMed Central http://www.biomedcentral.com/ Postprint available at: Linköping University Electronic Press http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-89759 Ström et al. BMC Neuroscience 2012, 13:146 http://www.biomedcentral.com/1471-2202/13/146 RESEARCH ARTICLE Open Access Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis Jakob O Ström1, Tobias Strid2 and Sven Hammarström2* Abstract Background: Leukotrienes are potent inflammatory mediators, which in a number of studies have been found to be associated with ischemic stroke pathology: gene variants affecting leukotriene synthesis, including the FLAP (ALOX5AP) gene, have in human studies shown correlation to stroke incidence, and animal studies have demonstrated protective properties of various leukotriene-disrupting drugs. However, no study has hitherto described a significant effect of a genetic manipulation of the leukotriene system on ischemic stroke. Therefore, we decided to compare the damage from focal cerebral ischemia between wild type and FLAP knockout mice. Damage was evaluated by infarct staining and a functional test after middle cerebral artery occlusion in 20 wild type and 20 knockout male mice.
    [Show full text]